The in vitro effect of trimethoprim on blastogenic transformation of human peripheral blood lymphocytes

Howard J. Rogers, Paul S. Lietman

Research output: Contribution to journalArticle

Abstract

Trimethoprim (TP) at concentrations of 1 × 10-6 to 1 × 10-3 M inhibits the incorporation of thymidine, uridine, formate, and leucine by human lymphocytes undergoing blastogenic transformation induced by conconavalin A. TP does not alter cell viability, as measured by trypan blue exclusion, or cell numbers. An effect of TP on dihydrofolate reductase, such as is seen with methotrexate, is insufficient to explain the inhibitory effects of TP since an in vivo estimation of dihydrofolate reductase activity, utilizing deoxyuridine incorporation into deoxyribonucleic acid, is not inhibited. Also the observed inhibition of precursor incorporation is not fully reversed by either folate or folinate. TP did not alter the percentage of cells transforming but reduced the number of autoradiographically-labelled lymphoblasts. Immunosuppression by TP in vivo may be associated with these findings.

Original languageEnglish (US)
Pages (from-to)1592-1599
Number of pages8
JournalBiochemical Pharmacology
Volume26
Issue number17
DOIs
StatePublished - Sep 1 1977
Externally publishedYes

Fingerprint

Trimethoprim
Lymphocytes
Blood
Tetrahydrofolate Dehydrogenase
formic acid
Deoxyuridine
Trypan Blue
Uridine
Folic Acid
Methotrexate
Leucine
Immunosuppression
Thymidine
In Vitro Techniques
Cell Survival
Cell Count
Cells
DNA

ASJC Scopus subject areas

  • Pharmacology

Cite this

The in vitro effect of trimethoprim on blastogenic transformation of human peripheral blood lymphocytes. / Rogers, Howard J.; Lietman, Paul S.

In: Biochemical Pharmacology, Vol. 26, No. 17, 01.09.1977, p. 1592-1599.

Research output: Contribution to journalArticle

Rogers, Howard J. ; Lietman, Paul S. / The in vitro effect of trimethoprim on blastogenic transformation of human peripheral blood lymphocytes. In: Biochemical Pharmacology. 1977 ; Vol. 26, No. 17. pp. 1592-1599.
@article{a4c91c143c8f4307a86493d499ccb4ec,
title = "The in vitro effect of trimethoprim on blastogenic transformation of human peripheral blood lymphocytes",
abstract = "Trimethoprim (TP) at concentrations of 1 × 10-6 to 1 × 10-3 M inhibits the incorporation of thymidine, uridine, formate, and leucine by human lymphocytes undergoing blastogenic transformation induced by conconavalin A. TP does not alter cell viability, as measured by trypan blue exclusion, or cell numbers. An effect of TP on dihydrofolate reductase, such as is seen with methotrexate, is insufficient to explain the inhibitory effects of TP since an in vivo estimation of dihydrofolate reductase activity, utilizing deoxyuridine incorporation into deoxyribonucleic acid, is not inhibited. Also the observed inhibition of precursor incorporation is not fully reversed by either folate or folinate. TP did not alter the percentage of cells transforming but reduced the number of autoradiographically-labelled lymphoblasts. Immunosuppression by TP in vivo may be associated with these findings.",
author = "Rogers, {Howard J.} and Lietman, {Paul S.}",
year = "1977",
month = "9",
day = "1",
doi = "10.1016/0006-2952(77)90074-0",
language = "English (US)",
volume = "26",
pages = "1592--1599",
journal = "Biochemical Pharmacology",
issn = "0006-2952",
publisher = "Elsevier Inc.",
number = "17",

}

TY - JOUR

T1 - The in vitro effect of trimethoprim on blastogenic transformation of human peripheral blood lymphocytes

AU - Rogers, Howard J.

AU - Lietman, Paul S.

PY - 1977/9/1

Y1 - 1977/9/1

N2 - Trimethoprim (TP) at concentrations of 1 × 10-6 to 1 × 10-3 M inhibits the incorporation of thymidine, uridine, formate, and leucine by human lymphocytes undergoing blastogenic transformation induced by conconavalin A. TP does not alter cell viability, as measured by trypan blue exclusion, or cell numbers. An effect of TP on dihydrofolate reductase, such as is seen with methotrexate, is insufficient to explain the inhibitory effects of TP since an in vivo estimation of dihydrofolate reductase activity, utilizing deoxyuridine incorporation into deoxyribonucleic acid, is not inhibited. Also the observed inhibition of precursor incorporation is not fully reversed by either folate or folinate. TP did not alter the percentage of cells transforming but reduced the number of autoradiographically-labelled lymphoblasts. Immunosuppression by TP in vivo may be associated with these findings.

AB - Trimethoprim (TP) at concentrations of 1 × 10-6 to 1 × 10-3 M inhibits the incorporation of thymidine, uridine, formate, and leucine by human lymphocytes undergoing blastogenic transformation induced by conconavalin A. TP does not alter cell viability, as measured by trypan blue exclusion, or cell numbers. An effect of TP on dihydrofolate reductase, such as is seen with methotrexate, is insufficient to explain the inhibitory effects of TP since an in vivo estimation of dihydrofolate reductase activity, utilizing deoxyuridine incorporation into deoxyribonucleic acid, is not inhibited. Also the observed inhibition of precursor incorporation is not fully reversed by either folate or folinate. TP did not alter the percentage of cells transforming but reduced the number of autoradiographically-labelled lymphoblasts. Immunosuppression by TP in vivo may be associated with these findings.

UR - http://www.scopus.com/inward/record.url?scp=0017652291&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017652291&partnerID=8YFLogxK

U2 - 10.1016/0006-2952(77)90074-0

DO - 10.1016/0006-2952(77)90074-0

M3 - Article

C2 - 302706

AN - SCOPUS:0017652291

VL - 26

SP - 1592

EP - 1599

JO - Biochemical Pharmacology

JF - Biochemical Pharmacology

SN - 0006-2952

IS - 17

ER -